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ABSTRACT
Removal of the chlorinated methanes, carbon tetrachloride (CT), chloroform (CF)
and dichloromethane (DCM), and the halogenated methane, trichlorofluoromethane
(commonly known as CFC-11 or Freon-11) from contaminated soil and groundwater
remains challenging.

Releases to the environment resulted from historically poor

disposal practices, as well as spills and leaks from underground storage tanks. Among
these three compounds, CF is considered the benchmark for evaluating the feasibility of
bioremediation, due to its typically high level of toxicity towards most anaerobic
prokaryotes. However, inhibitory effects of low concentrations of CFC-11 on anaerobes
have been reported as well. Bioremediation is an attractive option for clean-up, but
requires developments in the technology, especially when the concentrations present are
in the tens or hundreds of milligrams per liter. The focus of this thesis is on developing
improved methods to bioremediate high concentrations of CFC-11, CF, and DCM. In
particular, the research focused on further characterizing two enrichment cultures
previously developed at Clemson University. The DHM-1 enrichment culture
cometabolically degrades high concentrations of CT, CF and CFC-11 with corn syrup as
the electron donor and vitamin B12 as an essential cofactor. The DCM enrichment culture
uses DCM as its sole source of carbon and energy via fermentation, releasing formate and
acetate as major products.
The objectives of this research were 1) to determine a mass balance for fluoride
release during biodegradation of CFC-11 by DHM-1, in the presence of corn syrup and
B12; 2) to evaluate the effect of the dose of DHM-1 on the rate biodegradation of 500

ii

mg/L of CF; 3) to evaluate the tolerance of the Clemson DCM enrichment culture to
DCM concentrations greater than 500 mg/L; 4) to determine the effect of CF on DCM
biodegradation by Clemson’s DCM enrichment culture, including the potential for
acclimation to increasing concentrations of CF; 5) to confirm the accumulation of
hydrogen during DCM biodegradation by Clemson’s DCM enrichment culture; 6) to
evaluate the effect of hydrogen concentration on DCM biodegradation by Clemson’s
DCM enrichment culture; and 7) to further characterize the identity of the microbe
responsible for DCM biodegradation by Clemson’s DCM enrichment culture.
Experiments performed with the DHM-1 enrichment culture proved that in the
presence of corn syrup and vitamin B12, the culture completely biodegraded 26 mg/L of
CFC-11. On a molar basis, less than 6% of the CFC-11 consumed accumulated as
dichlorofluoromethane (HCFC-21) and chlorofluoromethane (HCFC-31). The balance of
the CFC-11 was defluorinated, based on stoichiometric release of fluoride. These results
confirm the ability of the DHM-1 enrichment culture to convert high concentrations of
CFC-11 into nonhazardous products. This result is consistent with previous research that
demonstrates the same ability of DHM-1 with CT and CF. The DHM-1 enrichment
culture was also able to biodegrade approximately 500 mg/L of CF when the inoculum
dose was as low as 10-8 percent by volume. These results demonstrate the potential to use
the culture for bioaugmentation of source areas, since the dose required is minor relative
to the volume of groundwater that could be treated.
Experiments performed with the DCM enrichment culture demonstrated an ability
to biodegrade at least 740 mg/L of DCM, indicating its potential usefulness in treating
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groundwater located near source areas containing dense, nonaqueous phase liquid
(DNAPL). The addition of up to 6% H2 (by volume) to the headspace did not affect the
degradation of DCM. With experiments designed to analyze the effect of CF on DCM
degradation, addition of 1 mg/L of CF to the enrichment culture completely inhibited
DCM biodegradation. CF concentrations of 0.1 to 0.8 mg/L slowed the rate of DCM
utilization but did not prevent it. Preliminary efforts suggest it will be possible to
gradually acclimate the DCM enrichment culture to CF concentrations above 1 mg/L.
Efforts to isolate the DCM degrading microbe from this culture by sequential dilution in
agar did not yield a pure culture; however, the process narrowed down the microbial
community and facilitated better microscopic observation. The dominant morphology
consisted of gram positive thick rods, thin rods and filaments. The rods were similar in
appearance and gram stain to Dehalobacterium, one of two genera known to grow on
DCM as a sole carbon and energy source via fermentation.
The results of this study provide definitive evidence in support of the ability of the
DHM-1 enrichment culture to degrade CFC-11 to non-hazardous end products, and
degrade high concentrations of CF with a volumetric inoculum dose as low as 10-8%.
Characterization of the DCM enrichment culture proved its ability to degrade high DCM
concentrations. Even though 1 mg/L of CF inhibited DCM degradation, preliminary
experiments set up to acclimate the culture to CF concentrations above 1 mg/L have
shown promise. In order to identify the microbe that grows on DCM, additional effort is
warranted to obtain a pure culture by making additional transfers in sequential agar
dilutions.
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CHAPTER ONE: INTRODUCTION AND OBJECTIVES
Halogenated methanes have been in widespread use worldwide for decades. This
includes the chlorinated methanes, carbon tetrachloride (CT), chloroform (CF) and
dichloromethane (DCM), and the halogenated methane, trichlorofluoromethane
(commonly known as CFC-11 or Freon-11). CT and CF have been used for a myriad of
applications including dry cleaning, production of pesticides, as a solvent for the
extraction of pharmaceuticals and as a precursor in the production of Freons. CT had a
long history of use in industry before it was banned in 1970 in consumer products in the
United States, followed by a complete ban in 1996 according to the Montreal protocol.
CFC-11 was widely used as a refrigerant, foam-blowing agent, aerosol propellant and
degreasing agent until 1996 when it was banned by the Montreal Protocol due to its
contribution to stratospheric ozone depletion (1). Widespread use of these compounds
combined with historically poor disposal practices, spills and leaks from underground
storage tanks and recalcitrance to biodegradation has led to substantial soil and
groundwater contamination. These compounds pose significant health and environmental
concerns, especially at hazardous waste sites.
Among the many options

for remediating contaminated

groundwater,

bioremediation offers numerous potential advantages, including sustainable, effective and
economic removal. However, applying bioremediation to halogenated methanes requires
developments in the technology, especially when the concentrations present are in the
tens or hundreds of milligrams per liter. Although halogenated methanes receive less
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attention than chlorinated ethenes, they are among the most significant groundwater
contaminants.

The focus of this thesis is on developing improved methods to

bioremediate high concentrations of CFC-11, CF, and DCM.
1.1 CF and CFC-11 biodegradation
The well-established toxicity and frequency of occurrence of CF in groundwater
poses significant challenges to its removal from the environment. As a consequence of
the above factors, the Agency for Toxic Substances and Disease Registry (ATSDR) 2011
Substance Priority List ranks CF eleventh overall, the third highest among chlorinated
organic compounds, after vinyl chloride and polychlorinated biphenyls. Although not
ranked as high as CF and CT on the ATSDR list of hazardous substances, CFC-11 is
often found as a co-contaminant with CF and CT in groundwater (2). Among these three
compounds, CF is considered the benchmark for evaluating the feasibility of
bioremediation, due to its typically high level of toxicity towards most anaerobic
prokaryotes (3). Inhibitory effects of low concentrations of CFC-11 on anaerobes have
been reported as well (4). At low concentrations of CFC-11 and in the absence of
vitamin B12, the predominant end-product of CFC-11 degradation by Methanosarcina
barkeri and sulfate-reducing microorganisms was dichlorofluoromethane, commonly
known as HCFC-21 (4-5). However, halogenated methanes are not an acceptable endpoint for successful bioremediation. HCFC-21 is toxic, with an inhalation exposure limit
(European MAK value) of 10 mg/m3 (6). Reductive dechlorination of HCFC-21 to
chlorofluoromethane (commonly known as HCFC-31) has been reported under
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methanogenic conditions (7). HCFC-31 is listed as a Group 3 carcinogen (8). In situ
bioremediation of CFC-11 requires complete conversion into non-toxic products.
The fermentative enrichment culture DHM-1 was developed by Shan et al. (9)
using soil and groundwater samples from a California industrial site. DHM-1 is the first
culture proven to cometabolically degrade high concentrations of CF, CT and CFC-11
(500 mg/L, 10 mg/L and 26 mg/L, respectively) in the presence of catalytic amounts of
B12 (i.e., 0.03 mol of B12 per mol of CT or CF). 14C analyses revealed that the dominant
end products of CF and CT transformation in the presence of DHM-1, corn syrup, and
B12 were CO, CO2 and organic acids (10); the presence of B12 shifts the pathway from
reductive dehalogenation to hydrolytic and substitutive pathways (11-12). Krone et al.
(11) demonstrated the abiotic reduction of CFC-11 when titanium(III) citrate served as
the electron donor and aquocobalamin as the catalyst, with CO representing 67% of the
products and a corresponding amount of fluoride release. HCFC-21, HCFC-31,
fluoromethane, and dichlorodifluroethane also accumulated; CO and fluoride are
acceptable end-points. Egli et al. (13) have noted that anaerobic dechlorination of
chlorinated methanes is often associated with microbes that possess the acetyl-CoA
pathway. The CO dehydrogenase in this pathway oxidizes CO to CO2. The formation of
dihalocarbenes (difluorocarbene in the case of CFC-11) during dehalogenation and
hydrolysis reactions for halomethanes are toxic to anaerobes. The addition of exogenous
B12 mitigates the toxic effects of these intermediate compounds on native coenzyme B12
and CO dehydrogenase (14).
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Although the high unit cost of B12 is a concern, Wang (15) showed that doses
lower than 3 mole percent are still effective for CF biodegradation by DHM-1. The
effect of B12 on the rate of CF biodegradation follows a Michaelis-Menton kinetic model,
with a half saturation coefficient of 0.005 mol B12 per mol CF. This information can help
in the selection of a cost-effective dose of B12 to facilitate the bioremediation of CF and
other halogenated methanes.
As with CT, reductive hydrolysis of CFC-11 to CO is well documented, as shown
in Figure 1.1. In a previous study with the DHM-1 enrichment culture, 14C-labeled parent
compounds were used to facilitate a complete mass balance of the daughter products of
CT and CF biodegradation (10). However, the prohibitive cost of

14

C-labeled CFC-11

precluded its use for the evaluation of daughter products formed.

An alternative

approach is to monitor release of fluoride, to determine if the non-volatile degradation
products have been defluorinated. One of the objectives of this thesis was to determine
the percentage of fluoride recovery following complete degradation of CFC-11, in the
presence of DHM-1, corn syrup, and B12.
The intended use for DHM-1 is bioaugmentation of source areas that contain CT,
CF and/or CFC-11.

Source areas often contain dense, non-aqueous phase liquids

(DNAPLs) that serve as a long-term source of groundwater contamination, with
concentrations of halogenated methanes in the tens or hundreds of milligrams per liter.
For bioaugmentation to be successful, it is necessary for the culture to grow under in situ
conditions. This translates to use of relatively low volumetric doses, e.g., less than 1%.
The previous work by Shan et al. (10) was based on 5% transfers of DHM-1. Although
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effective, this dose was too high to be of practical value. One of the objectives of this
thesis was to evaluate the effect of the DHM-1 inoculum dose on the culture’s ability to
biodegrade CF at 500 mg/L.
1.2 DCM biodegradation
DCM (also commonly known as methylene chloride) was predominantly used as
a paint and varnish stripper post World War II, with increased production over the years.
It was also used as an aerosol propellant and a degreasing agent, and in the production of
pharmaceuticals, adhesives and ink. However, post 1980, the production and demand for
DCM began to drop dramatically. This has been attributed to increased regulation and
concern over its carcinogenicity. The ATSDR 2011 Substance Priority List ranks DCM at
86 (2). The national primary drinking water regulations have set the maximum
contaminant level goal and maximum contaminant level (MCL) for DCM at zero and
0.005 mg/L, respectively. As of January 2000, the Environmental Protection Agency
(EPA) classified DCM as likely to be a human carcinogen by all routes of exposure.
Long-term exposure to DCM above the MCL reportedly causes liver problems and
increased risk to cancer (16).
In spite of its toxicity, the environmental fate of DCM is usually very favorable in
comparison to other halogenated compounds. DCM is used as the sole carbon and energy
source by several microorganisms under a variety of anaerobic conditions to produce
non-toxic products (including CO2, Cl- and organic acids). Under oxic conditions, DCM
is readily degraded by methylotrophic bacteria harboring glutathione-dependent
dehalogenases (17). A few studies have demonstrated DCM degradation under
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denitrifying (17), acetogenic (13, 18) and methanogenic conditions (19). Mägli et al. (20)
subsequently isolated a novel anaerobic bacterium, Dehalobacterium formicoaceticum
strain DMC, that uses DCM as its sole source of organic carbon and energy, forming
acetate and formate as products. They also proposed a pathway for DCM degradation by
strain DMC, as shown in Figure 1.2.
The DCM enrichment culture used in this research was developed by Wang (15),
using inoculum from a microcosm study conducted at Clemson University. It was
gradually acclimated to consume up to 500 mg/L of DCM, which inhibited
methanogenesis (21-22). Kanitkar (23) demonstrated that DCM can serve as the sole
electron donor for reductive dechlorination of tetrachloroethene to ethene. This is of
particular relevance for sites in which chlorinated ethenes and DCM are comingled.
Since reductive dechlorination of chlorinated ethenes to ethene requires the participation
of Dehalococcoides (at a minimum, for reduction of cis-dichloroethene to vinyl chloride
and ethene), and hydrogen is the only electron donor known for Dehalococcoides, use of
DCM as the only electron donor implies that hydrogen was one of the fermentation
products. Presumably this occurred via disproportionation of formate to hydrogen and
carbon dioxide. Kanitkar (23) measured hydrogen at the end of his experiments and it
was below detection. He mentioned that higher levels were detected in other studies with
the DCM enrichment culture, but no data were presented. One of the objectives of this
thesis was to provide evidence of hydrogen formation during fermentation of DCM by
the enrichment culture.
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The DCM fermentation pathway proposed by Mägli et al. (20) (Figure 1.2) is
summed up by the following equations:
3CH2Cl2 + CO2 + 4H2O→2HCOO− + CH3COO- +6Cl− + 9H+

(1.1)

HCOO− + H+ → CO2 + H2

(1.2)

Lee et al. (24) propose that DCM fermentation may yield hydrogen rather than formate:
3CH2Cl2 + 4H2O →CH3COO− + 2H2 + CO2 + 7H+ + 6Cl−

(1.3)

Each of these reactions is thermodynamically favorable under standard conditions, with
Gibbs free energies of -674, -43.4, and -681 kJ/mole of rxn, respectively (the free
energies of formation used to calculate these values are shown in Appendix A). However,
it is unknown if one of the intermediate steps may be inhibited by accumulation of H2.
Lee et al. (24) observed inhibition of DCM fermentation when 20% hydrogen was
present in the headspace of their enrichment culture. One of the objectives of this thesis
was to determine if accumulated hydrogen inhibits DCM fermentation by Clemson’s
DCM enrichment culture.
DCM is one of the most soluble of the halogenated organic solvents, reaching
approximately 20,000 mg/L at saturation at 20°C (25). Consequently, at hazardous waste
sites that have DNAPL pools of DCM, the aqueous phase concentration will likely be
above 1,000 mg/L. One of the objectives of this thesis was to evaluate the ability of
Clemson’s DCM enrichment culture to grow at DCM concentrations above 500 mg/L,
the highest level previously evaluated.
Grostern et al. (26) recently demonstrated that a Dehalobacter sp. reductively
dechlorinates CF to DCM via organohalide respiration. Interestingly, Justicia-Leon et al.
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(27) reported that a DCM-degrading culture also consisting of a Dehalobacter sp.
obtained from pristine river sediment, did not reductively dechlorinate CF to DCM;
instead, their enrichment fermented DCM to acetate. This suggests that distinct
Dehalobacter populations are responsible for CF reductive dechlorination and DCM
fermentation. This observation was verified in the report by Lee et al. (24) where an
enrichment culture from a subsurface aquifer in Sydney, Australia was found to
completely dechlorinate up to 40 mg/L of CF. First, CF was respired to DCM, followed
by fermentation of DCM to acetate, H2 and CO2. Dehalobacter lineages were found to be
responsible for both dehalorespiration and fermentation. This contrasts to the earlier view
that Dehalobacter spp. are strictly characterized as organo-halide respiring organisms and
could not use other substrates for growth (26, 28). However, the CF-degrading culture
studied by Lee et al. (24) was inhibited by high partial pressures of H2. Results from this
thesis will elucidate if accumulation of H2 by DCM fermentation inhibits the Clemson
DCM enrichment culture in a similar manner. The DCM-degrading culture developed by
Justicia-Leon et al. (27) was completely inhibited in the presence of 5 mg/L CF. For sites
co-contaminated with CF and DCM, bioaugmentation with a microbial consortium
consisting of both CF-to-DCM respiring Dehalobacter sp. and a DCM-fermenting culture
will hold significant promise in the complete detoxification of CF. The prospect exists
that fermentation of DCM can provide the electron donor needed for reduction of CF to
DCM, resulting in a mixed culture that requires no external inputs yet results in
degradation of CF to nonhazardous products. This would require acclimating a DCMfermenting culture to increasing concentrations of CF, as that seen in heavily
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contaminated sites. One of the objectives of this thesis was to evaluate the sensitivity of
the Clemson DCM enrichment culture to CF.
In addition to the Dehalobacter sp. reported by Justicia-Leon et al. (27)
Dehalobacterium, a member of the Firmicute phylum, also grows anaerobically on DCM
as a sole carbon and energy source.

Microscopic evaluation of Clemson’s DCM-

fermenting culture by Kanitkar (23) indicated the prevalence of gram positive short rods,
characteristic of Dehalobacterium formicoaceticum strain DMC. PCR amplification with
Firmicute specific primers and clone library construction with DNA from the DCM
enrichment culture revealed the presence of Firmicutes. One of the objectives of this
thesis was to further characterize the identity of the microbe responsible for fermentation
of DCM in Clemson’s enrichment culture.
Thus, the overall objective of this thesis was to evaluate strategies to remediate
high concentrations of CFC-11, CF and DCM in contaminated groundwater, focused
mainly on further characterizing the DHM-1 enrichment culture developed by Shan et al.
(9), and the DCM enrichment culture developed by Wang (15).
The specific objectives were:
1) To determine a mass balance for fluoride release during biodegradation of
CFC-11 by DHM-1, in the presence of corn syrup and B12;
2) To evaluate the effect of the inoculum dose of DHM-1 on the
biodegradation rate of 500 mg/L of CF;
3) To evaluate the tolerance of the Clemson DCM enrichment culture to
DCM concentrations greater than 500 mg/L;
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4) To determine the effect of CF on DCM biodegradation by Clemson’s
DCM enrichment culture, including the potential for acclimation to
increasing concentrations of CF;
5) To confirm the accumulation of hydrogen during DCM biodegradation by
Clemson’s DCM enrichment culture;
6) To evaluate the effect of hydrogen concentration on DCM biodegradation
by Clemson’s DCM enrichment culture; and
7) To further characterize the identity of the microbe responsible for DCM
biodegradation by Clemson’s DCM enrichment culture.
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CHAPTER TWO: MATERIALS AND METHODS
2.1 Chemicals and media
The purity and sources of chemicals used for this research were as follows. CF
(99.7%, Shelton Scientific), DCM (99.9%, Allied Signal) and CS2 (100%, J.T. Baker)
were obtained as neat liquids. Chloromethane (methyl chloride, 99%, Praxair) and
methane (99.99%, Matheson) were obtained as neat gases. A gas mixture of 30%
CO2/70% N2 was obtained from Airgas. High purity hydrogen gas (99.99%) was obtained
from National. Regular type corn syrup was obtained from Sweetener Products
Company. A stock solution of corn syrup was prepared (5 mM), with a chemical oxygen
demand (COD) of 360 mg/mL based on its presumed composition of glucose (C6H12O6).
USP grade Vitamin B12 (cyanocobalamin) was obtained from Research Organics Inc. All
other reagents were ACS reagent grade or higher.
The two enrichment cultures used in this research were grown in different types
of medium. The DHM-1 culture was grown in a previously described (29) mineral salts
medium (MSM-1), with the following modifications: NaCl and KH2PO4 were not added;
the concentrations of K2HPO4 and NaHCO3 were 0.41 g/L and 4.0 g/L, respectively; and
the headspace consisted of 30% CO2/70% N2. Sodium sulfide (0.5 mM) was added to
MSM-1 in an anaerobic chamber. A protocol for preparing MSM-1 is provided in
Appendix B.1. The DCM enrichment culture was maintained in a modified bicarbonate
and phosphate buffered medium, hereafter referred to as MSM-2.

A protocol for

preparing MSM-2 is provided in Appendix B.2. For the isolation of the microbe involved

11

in DCM degradation, a formulation was adapted from Mägli et al. (18) to prepare both
liquid medium (hereafter referred to as MSM-3) and semi-solid agar medium. A protocol
for preparing the both is provided in Appendix B.3.
2.2 Experimental design
This section is organized according to the objectives, with objectives #1 and #2
covering the DHM-1 enrichment culture and objectives #3 through #7 covering the DCM
enrichment culture.
2.2.1 Fluoride mass balance during CFC-11 degradation by DHM-1
Three sets of experiments were conducted to measure the percentage of fluoride
recovery during biodegradation of CFC-11 by the DHM-1 enrichment culture. CFC-11
was added to all but one treatment, to provide an initial aqueous phase concentration of
26 mg/L. The first experiment (Set I) consisted of three treatments (Table 2.1). All
received MSM-1, a 5% dose of the DHM-1 enrichment culture (v/v), 13.5 µM CS, and
136 µM B12 (approximately 22% of the total CFC-11 on a molar basis). Treatment A
received only CFC-11; B was used to determine the impact of CF on biodegradation of
CFC-11; and C served as a control for the DHM-1 culture, so only CF was added.
Fluoride concentrations were measured at the start and end of the incubation period
(based on complete removal of the CFC-11 and CF).
The treatments used for the Set II experiment are outlined in Table 2.2.
Treatment A received DHM-1, CS, and B12, while B12 was not added to treatment B (with
the expectation that this would slow the rate of CFC-11 degradation and alter the
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products formed). Treatments C and D served as abiotic controls, with and without B12
added, respectively. With Set II, fluoride concentration was monitored multiple times
throughout the incubation period, to examine if accumulation of fluoride coincided with
CFC-11 degradation.
The treatments for Set III were identical to Set II (Table 2.2). However, there
were several key difference between these sets:

1) For Set II, CFC-11 was added as a

neat liquid. Due to some concerns about the accuracy of this method, and its impact on
the outcome of the fluoride mass balance, CFC-11 was added to Set III as a methanol
stock solution. Introducing CFC-11 in methanol afforded better control over the amount
added; the presence of methanol did not affect CFC-11 degradation by the DHM-1
enrichment culture.; 2) For Set III, fluoride was measured only at the start and end of the
incubation period; and 3) For Set III, the DHM-1 culture was washed before adding it to
treatments A and B. The intent of washing was to remove the residual level of B12 and
soluble organics. Washing consisted of centrifuging 40 mL of the DHM-1 culture using a
SORVALL® Evolution™ RC superspeed centrifuge. The supernatant was decanted and
the concentrate was resuspended in 40 mL of freshly prepared MSM-1. This suspension
was centrifuged once more, the supernatant decanted, and the concentrate was again
resuspended in 40 mL of fresh MSM-1.
The experiments were performed in autoclaved 160 mL serum bottles, which
were prepared in an anaerobic chamber (Coy Laboratories) containing an atmosphere of
approximately 95% N2 and 5% H2. Resazurin (1 mg/L) was added to the MSM-1 to serve
as a redox indicator. Addition of Na2S·9H2O (120 mg/L) resulted in the medium turning
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clear, an indication that the Eh had dropped to below -110 mV. DHM-1 was then added to
the appropriate treatments (Tables 2.1 and 2.2). The bottles were then stoppered with
grey butyl septa and taken out of the anaerobic chamber. The headspace of the bottles
was sparged for 1 min with 30% CO2/70% N2 to remove the hydrogen and adjust the pH
to circumneutral. They were then sealed with Teflon-faced red rubber septa and
aluminum crimp caps. Lastly, CFC-11, CF, CS and B12 were added to the respective
treatments (Tables 2.1 and 2.2). The bottles were incubated (liquid in contact with the
septum) for at least 1 h on a shaker table and then headspace samples were analyzed to
determine the initial concentrations of the volatile compounds.
The pH of bottles was checked periodically and adjusted to 6.8 and 7.4 by the
addition of 8 M NaOH. Decreases in pH were most pronounced in bottles containing the
DHM-1 culture, CS and B12. This was indicative of the accumulation of organic acids, as
well as release of HCl and HF due to dehalogenation.
2.2.2 Effect of the DHM-1 inoculum dose on the rate of CF biodegradation
The experimental design for evaluating the effect of DHM-1 dose on CF
biodegradation employed 10 treatments (Table 2.3). One half of the treatments were
“live,” i.e., they received doses of DHM-1 ranging from 10-8 to 5.0% (v/v). Serial
dilutions of the DHM-1 culture were used to achieve varying initial doses. The other five
treatments consisted of various types of abiotic controls, according to whether or not CS
or B12 was added.
Treatments A through I were prepared in the same manner as described in the
previous section, starting with addition of MSM-1 to the 160 mL serum bottles in an
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anaerobic chamber. Aseptic technique was used to ensure the proper doses of DHM-1
were added and that no microbes were added to the controls. The water controls (WC)
were prepared on the bench top and received 100 mL of distilled deionized (DDI) water
plus 36 µL of neat CF.
2.2.3 Tolerance of the DCM enrichment culture to high DCM concentrations
Acclimation to increasing concentrations of DCM was gradually achieved in 160
mL serum bottles containing 100 mL of the DCM enrichment culture growing in MSM-2
(Appendix B.2). These bottles (labeled 5-1T, 5-2T and 5-3T) were inherited from
Kanitkar (23) and were maintained for this research. pH was monitored periodically; the
culture was observed to be sensitive to pH levels below ~6.5. To maintain the pH
between 6.8 and 7.4, 8 M NaOH was periodically added. To prevent an inhibitory
accumulation of salts (from NaOH neutralization of HCl), aliquots of culture were
periodically removed and replaced with fresh MSM-2.
2.2.4 Effect of CF and H2 on DCM biodegradation
In order to evaluate the effect of CF (1 mg/L) and increased partial pressures of
H2 on DCM biodegradation, experiments were set up in 70 mL serum bottles; treatments
are outlined in Table 2.4. The DCM enrichment culture (growing in a 2350 mL bottle)
was added (44 mL) to each of the bottles in an anaerobic chamber. The bottles were
immediately stoppered with grey butyl septa and removed from the glove box. The
headspace was sparged with 30% CO2/70% N2 and the bottles were sealed with
aluminum crimp caps. The pH was further adjusted between 6.8-7.4 by the addition of 8
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M NaOH. Treatment A received DCM and CF, while treatment B received DCM and H2.
Treatment C served as a control for DCM consumption (no CF or H2 added) and D as a
control for H2 consumption (no DCM added). When H2 was consumed, increasing
amounts were added, up to 60 µmol/bottle. pH was maintained between 6.8 and 7.4.
Preliminary results from this experiment indicated 1 mg/L of CF was inhibitory to
DCM biodegradation. Consequently, a second experiment was prepared at a series of
lower CF concentrations, ranging from 0.1 to 0.8 mg/L (Table 2.5). The bottles were
prepared in the same manner as described above.
2.3 Enrichment cultures
The DHM-1 culture developed by Shan et al. (9) was maintained in 160 mL
serum bottles by sequential transfers in MSM-1. Transfers were initiated by adding 5%
of the culture (v/v) along with MSM-1, CS, B12 and 500 mg/L CF, totaling 100 mL of
liquid. Once CF in the bottle was completely consumed (approximately 30 days), the
transfer process was repeated. At the time of each transfer, the excess culture was
available for use in experiments.
The DCM culture developed by Wang (15) was initially maintained in 160 mL
serum bottles containing MSM-2. Repeated additions of DCM were consumed; the pH
was maintained in the range of 6.8 and 7.4. As needed, samples were removed to initiate
experiments and the volume was replaced with MSM-2. For experiments that evaluated
inhibition by CF and H2, a larger supply of culture was needed. This was created by
transferring one of the serum bottles to a 2.35 L glass bottle, prepared with the same

16

liquid to headspace ratio as in the serum bottles. When samples of the culture were
removed, an equivalent volume of MSM-2 was added.
2.4 Analysis of volatile organic compounds
A Hewlett Packard 5890 Series II gas chromatograph (GC) equipped with a flame
ionization detector (FID) and a 2.44 m  3.175 mm column packed with 1% SP-1000 on
60/80 Carbopack B (Supelco) was used for the analysis of volatile organic compounds.
Halogenated (CF, DCM, CM, CFC-11, HCFC-21, HCFC-31) and nonhalogenated
volatile compounds (methane, methanol, CS2) were monitored by analysis of 0.5 mL
headspace samples using a Pressure-Lok analytical syringe (1.0 mL). Standard curves of
each of the above compounds provided a response factor which was used to quantify the
mass of the compound in the bottle. Results were reported in terms of micromoles per
bottle, in order to easily reveal the stoichiometry of the transformations. Representative
response curves are shown in Appendix A. Assuming that equilibrium is established
after the compound partitions between the gas phase and the aqueous phase, the aqueous
phase concentration is determined from the total mass of the compound present by the
following equation:
(2.1)

where Cl is the concentration in the aqueous phase (µM); M is the total mass present
(µmol/bottle); Vl is the volume of liquid in the bottle (L); Vg is the volume of headspace
(L); Hc is the dimensionless Henry’s constant at 23°C (30-31). The detection limit of this
method is lower than the MCL for each of the chlorinated compounds.
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2.5 Analysis of fluoride
Fluoride concentrations were quantified using a Dionex 2100 Ion Chromatograph
(IC). A mobile phase of degassed sodium carbonate/bicarbonate eluent (4.5 mM and 0.8
mM, respectively) was pumped (1.0 mL/min) through an IonPac® AG9-HC guard
column (4 mm x 50 mm), followed by an IonPac® AS9-HC anion-exchange column (4
mm x 250 mm. Samples (0.2 mL) from the serum bottles were prepared by a 1:50
dilution in DDI water, followed by filtration (0.2 µm PTFE) into 5 mL IC vials. Sample
dilution was essential to reduce interference from other anions in the MSM-1, especially
chloride. Samples were injected onto the column using a 250 µL injection loop. Fluoride
calibration standards were prepared according to EPA method 9214. A series of 1:50
dilutions of a stock solution (1,000 mg/L) was made in MSM-1; these were further
diluted 1:10 in DDI water (the same as the samples), yielding IC calibration standards of
2000, 1400, 1000, 500 and 100 µg/L. Standards were also filtered. A representative
calibration curve is shown in Appendix C.
The percent recovery of fluoride (RF) was calculated as follows:
(2.3)

where Ff and Fi = the final and initial fluoride concentrations (µM), respectively; Vl =
volume of liquid (0.10 L/bottle); CFC11i and CFC11f = the initial and final amounts of
CFC-11 (µmol/bottle), HCFC21f = final amount of dichlorofluoromethane (µmol/bottle);
HCFC31f = final amount of chlorofluoromethane (µmol/bottle). The initial amounts of
dichlorofluoromethane and chlorofluoromethane were zero.
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To assess the impact of quantifying fluoride in a complex matrix (i.e., MSM-1
and soluble biodegradation products), fluoride recovery was measured by standard
addition. After dilution (1:50) and filtration of samples from bottles with DHM-1, CS,
B12 and CFC-11, 5 mL was added to an IC vial. An aliquot (2.5 mL) of this solution was
mixed with 2.5 mL of the 1000 µg/L filtered IC standard in another vial. In a third vial,
2.5 mL of the 1000 µg/L standard was mixed with 2.5 mL of filtered DDI water. The
percentage recovery from this standard addition (RSF) was calculated by the following
equation:
(2.3)

where A is the fluoride concentration in the sample + standard (50:50 mixture by volume;
µg/L), B = fluoride concentration in the sample (µg/L), and C = concentration of the
fluoride standard after mixing 50:50 (v/v) with DDI water.
2.6 Agar dilution series and transfers
Isolation of the microbe in the DCM enrichment culture responsible for DCM
biodegradation involved induction of colony growth in Balch tubes by agar shake dilution
series, followed by transfer of individual colonies to liquid medium in Balch tubes, as
previously described (18). Two batches of agar shake tubes were prepared; one
containing DCM culture filtrate and the other without. All of the test tubes were serially
diluted.
For the batch of test tubes without culture filtrate, MSM-3 was prepared
according to Mägli et al. (18) (Appendix B.3). MSM-3 was made semi-solid by the
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addition of 0.3% agar (w/v), and 10 mL of it was transferred to six Balch tubes in an
anaerobic chamber. The tubes were immediately stoppered with grey butyl septa,
crimped and removed from the chamber. The headspace was sparged with filter sterilized
30% CO2/70% N2. The tubes were placed in a water bath on the bench top to melt the
agar. A thermometer placed in the water bath ensured that the temperature was between
45°C and 50°C. An aliquot (1 mL) of the enrichment culture was transferred to the first
Balch tube. The tube was gently swirled to mix the semi-solid medium and culture, and
to prevent the formation of gas bubbles. After mixing, 1 mL from the first tube was
transferred to the second tube. This procedure was repeated to get a dilution series of
10-1, 10-2, 10-3, 10-4, 10-5 and 10-6. Filter-sterilized DCM-saturated water (0.23 mL) was
added to each of the test tubes and gently swirled to mix. The tubes were removed from
the water bath and placed in the upright position in the dark. The tubes were checked
periodically for development of colonies.
The batch containing culture filtrate was prepared following the same
methodology as described above, except for the addition of filtrate from the DCM
enrichment culture, in a 50:50 combination with sterile MSM-3. The culture filtrate was
prepared by dispensing 55 mL of the enrichment culture to a centrifuge tube inside the
anaerobic chamber, removing the tube from the chamber, and centrifuging it (10,000
rpm, 20 min, SORVALL® Evolution™ RC superspeed centrifuge). The tube was
returned to the anaerobic chamber and the supernatant passed through a sterile 0.2 µm
syringe filter. Sterile culture filtrate and MSM-3 were mixed and the product was made
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semi-solid by the addition of 0.3% agar (w/v). Serially diluted tubes were prepared and
incubated in the same manner described above.
Whitish colonies were observed in the both batches of test tubes within 4-5 weeks
of incubation. Several colonies from the tubes were used to inoculate 10 mL of sterile
MSM-3 in Balch tubes. Individual colonies were transferred using a sterile Pasteur
pipette, sterile rubber tube and a 5 mL syringe to provide suction. Care was taken to
ensure that only a single colony was picked . More than 20 such colonies were transferred
to different test tubes. The tubes were sealed and taken out of the anaerobic chamber; the
head space was sparged with the filter sterilized CO2 +N2 gas mix; filter sterilized DCM
saturated water (0.23 mL) was added to each tube and incubated in an inverted position.
The head space was analyzed periodically to determine if the colonies were degrading
DCM.
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CHAPTER THREE: RESULTS
3.1 Characterization of DHM-1 enrichment culture
3.1.1 Fluoride mass balance during CFC-11 degradation
A mass balance for fluoride release during biodegradation of CFC-11 by the
DHM-1 enrichment culture in the presence of CS and B12 resulted in recoveries of 92102% (Table 3.1). These recoveries take into account the minor amount of fluoride that
resided in the CFC-11 dehalogenation daughter products, HCFC-21 and HCFC-31
(Figures 3.1-3.3). Thus, nearly all of the CFC-11 consumed by DHM-1 in the presence
of CS and B12 resulted in a stoichiometric increase in fluoride. Standard recoveries for
fluoride were approximately 100% (Appendix D), indicating the sample matrix imparted
no bias in determining fluoride concentrations.
Headspace monitoring results for the Set I treatment with DHM-1, CS and B12
(identified as I-A in Table 3.1) are shown in Figure 3.1. Results for the same treatment
but with 500 mg/L of CF also added (identified as I-B) are shown in Figure 3.2. The
initial increase in CFC-11 in comparison to the time zero value appears to be a
consequence of a disequilibrium between the headspace and aqueous phases.

The

presence of CF did not slow the rate of CFC-11 biodegradation, while the rate of CF
biodegradation was slowed by the presence of CFC-11. The presence of CF had no
impact on the fluoride mass balance for CFC-11 (Table 3.1).

Methane did not

accumulate throughout the incubation period and carbon disulfide, a potential hydrolytic
product from CFC-11 (Figure 1.1), was not detected.
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Figure 3.3 shows the results for CFC-11 and other volatiles in the Set II treatment
with DHM-1, CS and B12 (identified as II-A in Table 3.1), and for the treatment with only
MSM-1 (II-D). During this experiment, it is apparent that fluoride release coincided with
biodegradation of CFC-11. Over the same incubation period, the net decrease in CFC-11
(initial versus final value) was 6% in the treatment with only MSM-1 present. Headspace
monitoring results for treatments B and C are shown in Appendix E.2; biodegradation of
CFC-11 was incomplete in these bottles and yielded a lower mass balance for fluoride
compared to the treatment with CS and B12 added.
Results for CFC-11 in the Set III treatments are shown in Figure 3.4a. Complete
consumption of CFC-11 occurred only in treatment A (DHM-1, CS and B12 added). As
indicated in section 2.2.1, CFC-11 was provided dissolved in methanol to improve the
accuracy of addition (in comparison to adding a smaller volume of neat compound, as
was done in Sets I and II). The presence of methanol had no apparent impact on the rate
of CFC-11 biodegradation (comparing Figures 3.1-3.3 to 3.4).

Methanol was not

quantified but the peak area indicates it persisted while CFC-11 was present and then
decreased rapidly after CFC-11 was consumed. There was no net consumption of CFC11 in the treatments without B12 added (B and D), in comparison to partial degradation of
CFC-11 in the abiotic treatment with only B12 added (C). The fluoride balance was also
incomplete for this treatment, similar to what occurred with the same treatment for Set II
(Table 3.1). Headspace monitoring results for the individual treatments are shown in
Appendix E.3.
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3.1.2 Effect of DHM-1 inoculum dose on the rate of CF biodegradation
As indicated in Figure 3.5, biodegradation of 450-500 mg/L of CF proceeded at a
high rate even at an inoculum dose as low as 10-8 percent. Headspace monitoring
continued until CF fell below the MCL for trihalomethanes (80 µg/L). At a 5% inoculum
dose, 23 days of incubation was required. Previous subcultures of 5% inoculum also
degraded 500 mg/L CF in approximately 20 days (9), which provides evidence that the
CF biodegradation ability of the culture did not change significantly with time. The 10-8%
dose took 39 days to completely biodegrade CF.

Accumulation of DCM and CM

amounted to less than 0.6% of the CF consumed, which is consistent with results reported
by Shan et al. (9) for a 5% inoculum dose. Losses from uninoculated controls were
comparatively minor over the 39 days of incubation. These results demonstrate the
potential for DHM-1 to biodegrade 500 mg/L CF even at a low initial cell density, which
is an essential characteristic for use in bioaugmentation.
Maximum initial rates of CF biodegradation are summarized in Table 3.2,
expressed as mg CF L-1 d-1. The rates were determined by fitting a trend line to at least
the first three data points; other time points were included as long as the slope remained
statistically significant (p<0.025); an example is shown in Appendix E.4. Three of the
five uninoculated controls had statistically significant rates of decrease in CF, although
the rates were one to two orders of magnitude lower than that of the live treatments.
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3.2 Characterization of a DCM degrading anaerobic enrichment culture
3.2.1 Effect of DCM dose and hydrogen accumulation
The DCM enrichment culture was able to degrade successively higher doses of
DCM, as shown in Figure 3.6. Treatment 5-1T tolerated and degraded 914 µmol/bottle,
which is equivalent to 740 mg/L, the highest level tested. It is not yet known if the culture
will tolerate even higher concentrations. Maintenance of the pH became especially
demanding as the concentration was increased, due to the higher rate of release of HCl.
The effect of pH on the activity of the culture was not explicitly evaluated. However, on
occasions when the pH dropped below 6.4, the rate of DCM biodegradation slowed
significantly and recovery after raising the pH to circumneutral often took several weeks.
Accumulation of salts from acid neutralization also required that portions of the medium
be removed periodically and replaced with fresh MSM-2. Further work is needed to
define the effect of salt concentration on DCM biodegradation in the Clemson DCM
enrichment culture.
Increases in hydrogen were most pronounced shortly after adding DCM.
Hydrogen reached a maximum of approximately 27 µmol/bottle (Figure 3.6) and
typically decreased as the DCM was biodegraded. This observation confirmed the
availability of hydrogen from DCM to serve as an electron donor for reductive
dechlorination of PCE to ethene, as demonstrated by Kanitkar (23). It also formed the
basis for the experiment described below to determine if increased hydrogen
concentrations would cause a thermodynamic barrier to DCM degradation.
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3.2.2 Effect of H2 and CF on DCM degradation
The effect of hydrogen on DCM biodegradation was evaluated to determine if
high partial pressures of hydrogen inhibited DCM degradation. Thermodynamic
calculations for equations 1.1 to 1.3 predict the reactions will be favorable under standard
conditions (ΔG°’ < 0). Hence, hydrogen levels at least as high as 1 atm should not inhibit
these reactions. Experiments were performed in 70 mL serum bottles containing 44 mL
of the DCM enrichment culture. One set of triplicate bottles received DCM (173 mg/L
DCM) and increasing additions of hydrogen (from 4 to 60 µmol/bottle, or 0.4 to 6% of
the headspace volume); one set of controls received only DCM and another only
hydrogen.

Whenever DCM or hydrogen was consumed, more was added; rates of

consumption increased over time (Appendix F). As shown in Figure 3.7a, the presence
of added hydrogen did not slow the cumulative rate of DCM biodegradation; likewise,
the presence of DCM did not slow the rate of hydrogen consumption (Figure 3.7b). In
the controls with only hydrogen, approximately 60% of the electron donor (H2) was
converted to methane; in the treatments with DCM added, 16-22% of the electron donor
(DCM and H2) was recovered as methane. This indicated that 173 mg/L of DCM was not
completely inhibitory to methanogenesis, as it was when higher concentrations of DCM
were added (Figure 3.6). It is possible that some of the hydrogen was also converted to
organic acids, as reported by Kanitkar (23); however, organic acids were not quantified in
the research for this thesis.
The effect of CF on DCM biodegradation was also evaluated, since both
compounds may be present simultaneously in anaerobic groundwater. Experiments were
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performed in 70 mL serum bottles containing 44 mL of the DCM enrichment culture.
The first evaluation consisted of a treatment with DCM (173 mg/L) plus 1 mg/L of CF.
As shown in Figure 3.7a, this level of CF completely inhibited DCM biodegradation, in
comparison to the control that received DCM but no CF.
To determine the effect of lower CF doses, a second experiment was performed,
using the same experimental system described above. Increasing doses slowed the rate of
DCM biodegradation, but did not prevent it (Figure 3.8a); CF levels stayed relatively
constant throughout the incubation period, indicating that the DCM enrichment is unable
to biodegrade CF. All of the bottles subsequently received a second dose of DCM and an
increased dose of CF, to determine if acclimation to CF is possible. Although still in
progress, results suggest that DCM biodegradation is continuing at CF levels above 1
mg/L (Appendix G).
3.2.3 Isolation and microscopic observation of DCM fermenters
The microbial community within the DCM enrichment culture was investigated
using a light microscope. Phase contrast and gram staining techniques were applied using
oil immersion and 1000X magnification. Photomicrographs showed a diversity of
microbes in the enrichment culture, including gram positive rods and cocci, and gram
negative rods and filaments, enmeshed in iron sulfide particles from the MSM-2.
Following 6 weeks of incubation in the agar tubes, distinct colonies developed. A
random selection of colonies was picked and transferred aseptically to Balch tubes
containing MSM-3 and DCM saturated water. The relative amount of DCM remaining
was determined by headspace analysis. As shown for representative tubes in Figure 3.9,
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the DCM was consumed in approximately 44 days, in tubes inoculated with colonies
from dilutions with and without enrichment culture filtrate (suggesting that the filtrate
was not required).

A higher rate of DCM consumption ensued after respiking.

Consumption of DCM was accompanied by an increase in turbidity, indicative of growth.
Phase contrast and gram stain photomicrographs for samples taken from representative
Balch tubes are shown in Figure 3.10. Microbes from both tubes were gram positive. The
predominant morphology was thick single rods, which sometimes occurred in pairs.
These rods had an average length of 3.0 µm. This was followed by thin rods that occurred
as filaments or as single rods. These rods had an average length of 2.0 µm. These results
indicate that some of the rods observed may be Dehalobacterium sp., which is known to
be a gram positive short rod.
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CHAPTER FOUR: DISCUSSION
The results of this study provide information that will be helpful in applying
bioremediation to high concentrations of CFC-11, CF, and DCM. With respect to CFC11, the results demonstrated that the DHM-1 enrichment culture amended with CS and
B12 completely biodegraded 26 mg/L, with stoichiometric release of fluoride. Fluoride
recovery was close to 100% for all the bottles containing DHM-1, CS, and B12, with
minimal accumulation of HCFC-21 and HCFC-31. This indicates that the DHM-1 culture
has potential for application in the field to degrade high concentrations of CFC-11 (i.e.,
26 mg/L), with minimal formation of harmful intermediate fluorinated products. Hence,
the potential exists for using this culture to biodegrade CF, CT and CFC-11 to non-toxic
end products. Treatments that contained DHM-1 and CS, but no B12, showed negligible
CFC-11 and fluoride release, similar to the treatments that contained no inoculum. This
demonstrates the crucial catalytic role played by B12 in biotransformation (32). However,
sterile treatments in sulfide-reduced MSM-1 that contained B12 showed a significant level
of CFC-11 consumption and fluoride release. This is attributed to abiotic degradation
with the influence of the sulfide-reduced MSM-1 and B12 (33).
Results from the DHM-1 inoculum dose experiment established that levels below
what was previously tested (i.e., 5% v/v) (9) are feasible for biodegrading CF
concentrations of approximately 500 mg/L. As shown in Figure 3.5 and Table 3.2, CF
degradation rates with a 5% dose and a 10-2% dose were not significantly different.
Lower doses of 10-4% , 10-6%, and 10-8% also showed significant rates of CF
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biodegradation. An inoculum dose of 5% would be impractical for field applications.
Bioaugmentation field tests at Department of Defense facilities (34) have shown that a
dose of 10-3% by volume was required to effectively remediate chlorinated-ethene
contaminated sites by addition of an enrichment culture dominated by Dehalococcoides.
For chlorinated ethenes, a commonly used target is 107 cells/L of Dehalococcoides (34).
Assuming a unit mass of 1.6x10-14 g/cell (35) and one half of the cell mass is protein,
this equates to a dose of 8x10-5 mg/L protein. DHM-1 was able to biodegrade 500 mg/L
of CF at a high rate with a volumetric dose as low as 10-8%; this equates to a
concentration of 10-8 mg/L protein, several orders of magnitude lower than the target for
Dehalococcoides. This suggests that achieving an adequate dose in situ will not be
problematic, thereby improving its potential for use in bioaugmentation. Among the
sterile controls, those that contained B12 showed a slow decrease in CF levels, which can
be attributed to abiotic degradation in the presence of B12. The sterile water treatment and
controls without B12 did not show a decrease in CF.
Several characteristics of the DCM degrading culture revealed by this study lends
itself to application of the culture at field sites where high concentrations of DCM are
found. The biodegradative capability demonstrated by the DCM enrichment culture is
amenable in locations where high concentrations of DCM are found. As shown in panel a
of Figure 3.6, the enrichment culture has the ability to degrade at least 740 mg/L DCM;
the highest concentration reported previously is 425 mg/L (36). Additional studies are
needed to determine just how high a DCM concentration the Clemson enrichment culture
can tolerate. However, since the culture is sensitive to decreases in pH below ~6.5,
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buffering agents need to be added periodically, along with attention to avoiding an
inhibitory accumulation of salts from neutralization (37).
CF has an inhibitory effect on DCM degrading microbes, as reported in previous
studies (27). This was visible in the treatment containing 1 mg/L CF and 173 mg/L in this
research (Figure 3.7a). However, treatments with CF levels below 1 mg/L did not show
complete inhibition of DCM removal, albeit, the treatment with 0.8 mg/L CF showed
slower DCM degradation than the treatment with 0.1 mg/L CF (Figure 3.8). The bottles
that demonstrated DCM removal in the presence of CF were respiked with 173 mg/L of
DCM and a CF concentration higher than the initial amount to deduce the tolerance as
well as acclimate the culture to higher CF levels. A culture that tolerates sufficiently high
concentrations of CF could be used as a bioaugmentation culture at CF contaminated
sites. A previous study showed that Dehalobacter spp. are responsible for the reductive
dechlorination of CF to DCM (26). This was followed by another study showing the
involvement of another Dehalobacter sp. that fermented DCM to acetate (27). A recent
report by Lee et. al (24) demonstrated the complete dechlorination of up to 40 mg/L CF
by Dehalobacter lineages; Dehalobacter sp. were responsible for both reductive
dechlorination of CF to DCM, followed by fermentation of DCM to acetate, CO2 and H2.
A signficant disadvantage of the co-culture developed by Lee et al. (24), however, was
the fact that accumulation of hydrogen inhibited DCM fermentation. Further studies are
required to develop a microbial consortium consisting of CF dechlorinators and DCM
fermenters that can effectively detoxify high concentrations of CF, as occurs in the
vicinity of DNAPLs, on the order of hundreds of micrograms per liter.
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Unlike CF, hydrogen did not inhibit DCM fermentation, at least at the highest
level tested in this research (6% of the headspace). The lack of inhibition is consistent
with predictions based on Gibbs free energy change for each of the fermentation
reactions that may be involved in the pathway (equations 1.1-1.3), i.e., the free energy
change is negative at standard conditions, which presumes 1 atm concentration of
hydrogen. What is more surprising is the fact that Lee et al. (24) reported inhibition of
DCM fermentation by hydrogen at 20% of the headspace volume; their observation is not
in agreement with thermodynamic expectations. Nevertheless, additional testing of the
Clemson DCM culture at higher hydrogen concentrations will help establish a potential
limit for inhibition.
Photomicrographs of the enrichment culture showed a diversity of microbes; it
included gram positive rods and cocci, along with gram negative rods and filaments,
enmeshed in iron sulfide particles in the medium. Growth of colonies from an aliquot of
this culture in agar dilution series, followed by the transfer of individual colonies to
liquid medium allowed narrowing down the microbial community to DCM degraders and
a few contaminants. This was represented by a smaller range of morphology, mainly
gram positive thick rods, thin rods and filaments. These results indicate that some of the
rods observed may be Dehalobacterium, which are gram positive short rods (18, 20). It
should be possible to further purify the culture by successive dilutions in agar, followed
by 16S rDNA sequencing to establish the identity of the isolate.
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CHAPTER FIVE: CONCLUSIONS AND RECOMMENDATIONS
Based on the experiments performed with the DHM-1 enrichment culture, the
following conclusions were reached:
i.

In the presence of CS and B12, the DHM-1 enrichment culture completely
biodegraded 26 mg/L of CFC-11. On a molar basis, less than 6% of the CFC-11
consumed accumulated as HCFC-21 and HCFC-31. The balance of the CFC-11
was defluorinated, based on a stoichiometric release of fluoride. These results
confirm the ability of the DHM-1 enrichment culture to convert high
concentrations of CFC-11 into nonhazardous products. This result is consistent
with previous research that demonstrated the same ability with CT and CF.

ii.

The DHM-1 enrichment culture was able to biodegrade ~500 mg/L of CF when
the inoculum dose was as low as 10-8 percent by volume. Using such a low
inoculum volume reduced the maximum rate of CF biodegradation, although the
time required to consume the CF was increased by only a few days. These results
demonstrated the potential to use the DHM-1 enrichment culture for
bioaugmentation of source areas, since the dose required is minor relative to the
volume of groundwater that could be treated.

Based on the experiments performed with the DCM enrichment culture, the
following conclusions were reached:
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i.

The enrichment culture is able to biodegrade at least 740 mg/L of DCM (the
highest concentration reported thus far), indicating its potential usefulness in
treating groundwater located near source areas containing DNAPL.

ii.

DCM biodegradation was not inhibited by the addition of H2, at least up to H2
levels of ~6% headspace volume. This result was consistent with predictions
based on Gibbs free energy changes for DCM fermentation to formate and
formate disproportionation to H2, as well as direct fermentation of DCM to
acetate and H2.

iii.

Addition of 1 mg/L of CF to the DCM enrichment culture completely inhibited its
biodegradation of DCM. CF concentrations of 0.1 to 0.8 mg/L slowed the rate of
DCM utilization but did not prevent it. Preliminary efforts suggest it will be
possible to gradually acclimate the DCM enrichment culture to CF concentrations
above 1 mg/L.

iv.

Growth of the DCM enrichment culture in agar, followed by transfer of individual
colonies to liquid medium, did not yield a pure culture. However, the process did
facilitate further enrichment that allowed for better microscopic observation. The
dominant morphology consists of gram positive thick rods, thin rods and
filaments. The rods are similar in appearance and gram stain to Dehalobacterium,
one of two genera known to grow on DCM as a sole carbon and energy source via
fermentation.
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The following recommendations are offered:
i.

Due to the high unit cost of B12, selection of a cost-effective dose of B12 is needed
when it is used as an amendment to facilitate the bioremediation of halomethanes.
Further research is required to define the Michaelis-Menten relationship between
B12 dosage and the rate of CFC-11 biodegradation, as has been done previously
with CF.

ii.

Further studies should be conducted to determine if the Clemson enrichment
culture can biodegrade DCM at levels greater 740 mg/L. This was the highest
level tested and it turned out not to be inhibitory, although it did present a greater
challenge in terms of avoiding a sharp drop in pH or too high an accumulation of
salts from neutralization.

iii.

On-going studies to evaluate acclimation of the DCM enrichment culture to CF
should be continued.

If acclimation is accomplished, the potential exists to

develop a co-culture that ferments DCM to organic acids and H2, which could be
used as the electron donor for organohalide respiration of CF to DCM.
iv.

Now that a procedure has been demonstrated to grow the DCM enrichment
culture in agar dilutions, further effort is warranted to obtain a pure culture by
making additional transfers. It would then be possible to identify the microbe that
grows fermentatively on DCM.
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TABLES

Table 2.1: Experimental design for Set I, F- mass balance from CFC-11
Treatmenta

# Bottles

CFC-11 (mg/L)b

CF (mg/L)c

A: DHM-1 with CFC-11

4

26

0

B: DHM-1 with CFC-11 + CF

4

26

500

C: DHM-1 with CF

2

0

500

a

Microcosms were prepared in quadruplicate in 160 mL bottles with 100 mL liquid;
each bottle had 93 mL MSM-1, 5 mL DHM-1 inoculum, 0.27 mL CS stock solution (5
mM) and 1.84 mL B12 stock solution (7.38 mM).
b
Obtained by adding 5.6 µL neat compound.
c
Obtained by adding 36 µL neat compound.

Table 2.2: Experimental design for Sets II and III, F- mass balance from CFC- 11
DHM-1
(mL/btl)

CS
(mg/L COD)b

B12
(µM)c

CFC-11
(mg/L)d

MSM-1
(mL/btl)

A: DHM-1-B12-CS

5

972

136

26

92.9

B: DHM-1-CS

5

972

0

26

94.7

C: B12

0

0

136

26

98.2

D: None

0

0

0

26

100.0

a

Treatment

a

Microcosms were prepared in triplicate in 160 mL bottles with 100 mL liquid.
Obtained by adding 0.27 mL of 5 mM CS stock solution.
c
Obtained by adding 1.84 mL of 7.38 mM vitamin B12 stock solution.
d
Obtained by adding 5.6 µL neat compound for Set II; 20 µL of CFC-11 in methanol
stock solution (0.415 g CFC-11/g stock) for Set III.
b
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Table 2.3: Experimental design for the effect of DHM-1 dose on CF biodegradation

Treatmenta
A

CS
%
DHM-1 Inoculum (mg/L
COD)c
Inoculum dilutionb
(mL)
5.0
1:1
5.000
972

B12
(µM)d
136

CF
(mg/L)e
500

MSM-1
(mL/btl)
90.4

B

1.0E-02

1:10

0.100

972

136

500

95.3

C

1.0E-04

1:103

0.100

972

136

500

95.3

D

1.0E-06

1:103

0.001

972

136

500

95.4

E

1.0E-08

1:105

0.001

972

136

500

95.4

F

0

0

0

972

136

500

95.4

G

0

0

0

0

136

500

98.1

H

0

0

0

0

0

500

100.0

I

0

0

0

972

0

500

97.3

WC

0

0

0

0

0

500

100.0

a

Microcosms were prepared in triplicate in 160 mL bottles with 100 mL liquid.
DHM-1 inoculum was serially diluted before addition to microcosms (v/v).
c
Obtained by adding 2.7 mL of 0.5 mM filter-sterilized CS stock solution.
d
Obtained by adding 1.84 mL of 7.38 mM filter-sterilized vitamin B12 stock solution.
e
Obtained by adding 36 µL neat compound.
b
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Table 2.4: Experimental design for the effect of CF and H2 on DCM biodegradation
a

b

DCM (mg/L)

c

DCM culture
(mL/btl)

H2
(µmol/btl)d

Treatment

CF (mg/L)

CF + DCM

1

173

44

0

H2 + DCM

0

173

44

4 to 60

DCM

0

173

44

0

H2

0

0

44

4 to 60

a

Microcosms were prepared in duplicate in 70 mL bottles with 44 mL of liquid.
Obtained by addition of 6 µL of CF-saturated water.
c
Obtained by addition of 6 µL of neat compound.
d
Obtained by addition of H2 gas, ranging from 0.1 to 1.5 mL.
b

Table 2.5: Experimental design for the effect of varying CF doses on DCM
biodegradation
Treatment
A

CF (mg/L)
0

DCM (mg/L)
173

DCM culture
(mL/btl)
44

B

0.1

173

44

C

0.2

173

44

D

0.4

173

44

E

0.6

173

44

F
WCd

0.8
0.8

173
173

44
0

a

b

c

a

Microcosms were prepared in triplicate in 70 mL serum bottles with 44 mL of liquid.
Obtained by addition of 36-284 µL of 1:50 diluted CF-saturated water.
c
Obtained by addition of 6 µL of neat compound.
d
Water controls had 44 mL of autoclaved DDI instead of DCM culture.
b
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Table 3.1: Summary of CFC-11 and fluoride release analysis

Description

CF
(mg/L)

CFC-11 consumed
(µmol/bottle)

Fluoride
released
(µmol/bottle)

CHCl2F
formed
(µmol/bottle)

CH2ClF formed
(µmol/bottle)

Fluoride
Recovery
(%)b

I-A

DHM-1 + CS + B12

0

60.1 ± 0.44a

54.0 ± 1.8

4.5 ± 0.1

0.20 ± 0.12

97.4 ± 3.8

I-B

DHM-1 + CS + B12

500

60.9 ± 0.00

55.9 ± 1.6

2.8 ± 0.1

2.15 ± 0.28

99.9 ± 3.1

II-A

DHM-1 + CS + B12

0

60.9 ± 0.00

63.9 ± 5.7

2.2 ± 0.1

0.34 ± 0.10

102.2 ± 8.8

II-B

DHM-1 + CS

0

-c

-

-

-

-

II-C

MSM-1 + B12

0

29.19 ± 2.14

21.77 ± 2.28

0.33 ± 0.04

0.04 ± 0.02

75.4 ± 2.2

II-D

MSM-1, no B12

0

3.44 ± 2.77

0

0.04 ± 0.03

0.04 ± 0.03

0

III-A

DHM-1 + CS + B12

0

65.2 ± 2.05

57.5 ± 1.6

2.3 ± 0.2

0.13 ± 0.03

91.8 ± 5.3

III-B

DHM-1 + CS

0

1.8 ± 1.2

0

0.9 ± 0.1

0.09 ± 0.04

0

III-C

MSM-1 + B12

0

25.0 ± 0.6

13.5 ± 2.5

0.7 ± 0.3

0.08 ± 0.07

55.6 ± 8.5

III-D

MSM-1, no B12

0

0

0.2 ± 0.3

0.1 ± 0.03

0.40 ± 0.28

0

BatchTreatment
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a

± = Standard deviation.
(µmol of F- released/µmol of CFC-11 consumed/bottle)*100
c
Results not reported due to carryover of B 12
b

39

Table 3.2: Summary of CF degradation rates, DHM-1 inoculum dose study

a
b

Treatmenta

% Inoculum (v/v)

CF degradation rate
(mg/L/day)b

No. of
timepoints
included

A

5.0

30.1 ± 1.5

3

B

1.0E-02

22.7 ± 0.6

4

C

1.0E-04

20.2 ± 1.0

4

D

1.0E-06

17.3 ± 0.9

4

E

1.0E-08

17.0 ± 0.8

4

F

0

2.3 ± 0.3

5

G

0

1.2 ± 0.3

5

H

0

0

5

I

0

0.6 ± 0.2

5

WC

0

0

5

Average of triplicates in 160 mL serum bottles with 100 mL liquid.
Slopes and standard errors obtained from regression analysis. Slopes are statistically
significant (p < 0.025).
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FIGURES

Figure 1.1: Pathways for biotransformation of CT, CF, and CFC-11 under low redox
conditions. [H]= H+ + e-.
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Figure 1.2: Pathway proposed by Mägli et al. (38) for anaerobic biodegradation of DCM
by strain DMC; THF = tetrahydrofolate.

Figure 3.1: Average of Set I-A treatment containing DHM-1, CS, B12 and CFC-11. Error
bars represent the standard deviation of quadruplicate bottles. Arrows represent the
addition of corn syrup. Fluoride was measured at the start and end of the incubation
period.
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Figure 3.2: Average of Set I-Btreatment containing DHM-1, CS, B12, CFC-11 and CF; a)
CFC-11 degradation and b) CF degradation. Error bars represent the standard deviation
of quadruplicate bottles. Arrows represent the addition of corn syrup. Fluoride was
measured at the start and end of the incubation period.
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Figure 3.3: Average of Set II microcosms. Live bottles contained DHM-1, CS, B12 and
CFC-11 (treatment A). The control (CFC-11-MC) contained only MSM and CFC-11
(treatment D). CHCl2F, CH2ClF, CH4, and fluoride are for the live treatment only. Error
bars show standard deviations of triplicate bottles. Arrow represents the addition of corn
syrup to the live treatment. Fluoride was monitored over time.
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a

b

Figure 3.4: Average of Set III treatments; a) CFC-11 in all treatments and b) volatile
compounds other than CFC-11 in the live treatment with DHM-1, B12, and CS added.
Fluoride was measured at the start and end of the incubation period. Error bars show
standard deviation of triplicate bottles. Arrow represents the addition of corn syrup to live
treatments.
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Figure 3.5: CF degradation with different inoculum doses of DHM-1. Treatments A
through E contained DHM-1, CS and B12. Treatments F through I were sterile. Water
controls were sterile with no CS or B12 added. Error bars show standard deviation of
triplicate bottle.

46

a

b

c

Figure 3.6: DCM enrichment culture in 160 mL serum bottles degrading increasing
DCM doses; a) bottle 5-1T, b) bottle 5-2T and c) bottle 5-3T.
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a

b

c

Figure 3.7: Cumulative DCM and H2 consumption in enrichment cultures; a) DCM
consumption in treatments containing only DCM (-CF, -H2); with DCM and CF (+CF);
with DCM and H2 (+H2), b) H2 consumption in treatments containing only H2 (-DCM);
with DCM and H2 (+DCM) and c) methane formation in all treatments. Figure shows the
average of duplicates.
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a

b

Figure 3.8: CF inhibition of DCM degradation; a) DCM consumption in microcosms
containing different concentrations of CF and b) CF levels in microcosms set up to assess
CF inhibition of DCM. Error bars show standard deviation of triplicate bottles.
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Figure 3.9: DCM levels in representative Balch tubes observed in terms of peak area
units on the GC. DCM was respiked when the level decreased to zero.
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10 µm

a

10 µm

b

Figure 3.10: Photomicrographs (1000X) for a) phase contrast of a sample grown from a
single colony in MSM-3 in a Balch tube; and b) a gram stain for a sample from a
different Balch tube.
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APPENDICES
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Appendix A: GC response factors and standard curves
Table A.1: GC TCD response factors for hydrogen at 23°C
RF (µmol/bottle/peak

a
b

Compound

GC RT (min)

area unit)

R2

Hydrogena

1.2

1.02E-04

0.9999

Hydrogenb

1.2

5.093E-05

0.9996

Based on liquid volume of 100 mL and gas volume of 60 mL in a 160 mL serum bottle.
Based on liquid volume of 44 mL and gas volume of 26 mL in a 70 mL serum bottle.

Table A.2: GC FID response factors for volatile organic compounds at 23°C a

a

RF (µmol/bottle/peak

Conversion factor

area unit)

(µmol/bottle to mg/L)

Compound

GC RT (min)

Methane

0.5

3.981E-06

0.0002

CCl3F

5.8

1.130E-05

0.4188

CF

7.1

4.571E-05

1.1052

CH2ClF

1.9

1.095E-04

0.5830

CHCl2F

4.2

7.776E-05

0.9109

CM

1.2

1.221E-05

0.4248

CS2

5.4

7.223E-04

0.5150

DCM

4.6

5.315E-05

0.8101

Based on liquid volume of 100 mL and gas volume of 60 mL in a 160 mL serum bottle.
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Table A.3: GC FID response factors for volatile organic compounds at 23°C (70 mL)
RF

a

GC RT

(µmol/bottle/peak

Conversion factor

Compounda

(min)

area unit)

R2

(µmol/bottle to mg/L)

Methane

0.5

9.7480E-07

0.9999

0.0005

CF

7.1

1.461E-05

0.9918

2.5147

CM

1.2

5.279E-06

0.9999

0.9679

DCM

4.6

1.977E-05

0.9957

1.8425

Based on liquid volume of 44 mL and gas volume of 26 mL in a 70 mL serum bottle.
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a

b

Figure A.1: GC TCD response curves for hydrogen in a) 100 mL liquid phase and 60 mL
gas phase and b) 44 mL liquid phase and 26 mL gas phase.
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a

b

Figure A.2: GC FID response curves for a) CFC-11 and b) methane, in bottles with 44
mL liquid and 26 mL headspace.
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a

b

c

Figure A.3: GC FID response curves for a) CF, b) DCM and c) CM, in bottles with 44
mL liquid and 26 mL headspace.
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Table A.4: Standard free energy of formation values (ΔGf, aq)
Compound

ΔGf, aq (kJ/mol)

Reference

DCM

-67.03

A and B

Water

-237.17

C

CO2

-394.4

C

Proton

-39.83

C

Hydrogen

0

C

Formate

-351.04

C

Acetate

-369.41

C

Chloride

-131.3

D

References
A: Reid, R. C., J. M. Prausnitz, and T. K. Sherwood. 1977. The Properties of Gases
and Liquids, 3rd edition. McGraw-Hill Book Company, New York.
B: Freedman, D. L., and J. M. Gossett. 1991. Biodegradation of dichloromethane
and its utilization as a growth substrate under methanogenic conditions. Appl.
Environ. Microbiol. 57:2847-2857.
C: Madigan, M.T., Martinko, J.M., Stahl, D. and Clark, D.P. Brock Biology of
Microorganisms, 12th edition. Prentice Hall, Inc., New Jersey.
D: Stumm, W. and Morgan, J.J. 1996. Aquatic Chemistry, Chemical Equilibria and
Rates in Natural Waters, 3rd edition. John Wiley & Sons, Inc., New York.
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Appendix B.1: Media preparation for DHM-1 culture (MSM-1)
Solutions needed for media:
-Trace Metal Solution
In a 1 L volumetric flask, add 1500 mg of FeCl 2∙4H2O, 190 mg of CoCl2∙6H2O,
100 mg of MnCl2∙4H2O, 70 mg of ZnCl2, 6 mg of H3BO4, 36 mg of
Na2MoO4∙2H2O, 24 mg of NiCl2∙6H2O, and 2 mg of CuCl2∙2H2O. Fill to 1 L with
DDI water.
-Selenite Solution
In a 1 L volumetric flask, add 3 mg of Na2SeO3 and 5 mg of NaHCO3. Fill to 1 L
with DDI water.
-Ferrous Solution
In a 1 L volumetric flask, add 3 mg of FeCl2·4H2O and 5 mg of NaHCO3. Fill to 1
L with DDI water.
-Redox Solution
In a 100 mL volumetric flask, add 0.1 g resazurin. Fill to 100 mL with DDI
water.
-Yeast Extract Solution
In a 100 mL volumetric flask, add 5 g yeast extract. Fill to 100 mL with DDI
water.
Media Preparation:
In a 1 L volumetric flask, add 300 mg of NH4Cl, 300 mg of KCl, 150 mg of CaCl2·2H2O,
400 mg of MgCl2·6H2O, 410 mg of K2HPO4, 4 g of NaHCO3, 1 mL of trace metal
solution, 1 mL of selenite solution, 1 mL of ferrous solution, 1 mL of redox solution, and
1 mL of sterilized yeast extract solution. Fill to 1 L with autoclaved DDI water. Transfer
to 1 L bottle and purge with 30% CO2/70% N2 for a few minutes until complete
dissolution of mineral salts. Add 120 mg of Na2S·9H2O crystals that have been rinsed
and blotted dry with Kimwipes in a completely anaerobic chamber and allow solution to
turn from blue to clear.
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Appendix B.2: Media preparation for DCM culture (MSM-2)
Solutions needed for media:
- Phosphate buffer
In a 100 mL volumetric flask add 5.25 g K2HPO4. Fill to 100 mL with DDI water.
- Salt solution
In a 100 mL volumetric flask add 5.35 g NH4Cl, 0.46976 g CaCl2:2H2O, and
0.17787 g FeCl2:H2O. Fill to 100 mL with DDI water.
- Trace metals solution
In a 100 mL volumetric flask add 0.03 g H3BO3, 0.0211 g ZnSO4:7H2O, 0.075 g
NiCl2:6H2O, 0.1 g MnCl2:4H2O, 0.01 g CuCl2:2H2O, 0.15 g CoCl2:6H2O, 0.002 g
Na2SeO3, 0.01 g Al2(SO4)3:16H2O, and 1 mL concentrated HCl. Fill to 100 mL
with DDI water.
- Magnesium sulfate solution
In a 100 mL volumetric flask add 6.25 g MgSO4:7H2O. Fill to 100 mL with DDI
water.
- Bicarbonate solution
In a 500 mL volumetric flask add 8.0 g NaHCO3. Fill to 500 mL with DDI water.
- Redox solution
In a 10 mL volumetric flask add 0.01 g resazurin. Fill to 10 mL with DDI water.
- Ferrous sulfide solution
To be added directly to autoclaved media in glove box after adding filtersterilized solutions. For 1 L, weigh out 0.24g of Na2S.9H2O and 0.1448g
FeCl2:H2O based on stock concentrations of 24 g/L and 14.48 g/L, into separate
vials. Add the Na2S:9H2O and allow media to clear. Add the FeCl2:H2O and
rinse both vials out with the 10 mL of autoclaved DDI water needed to balance
the solution and add to the media.
-Yeast extract solution
In a 100 mL volumetric flask add 0.5 g yeast extract. Fill to 100 mL with DDI
water.
Media Preparation:
In a 1 L bottle add 10 mL phosphate solution, 10 mL salt solution, 2 mL trace
metals solution, 2 mL magnesium sulfate solution, 1 mL redox solution, and 905 mL DDI
water. Autoclave this solution, and then add 50 mL filter sterilized bicarbonate solution
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and 10 mL filter sterilized yeast extract. In the glove box, add the 10 mL ferrous sulfide
solution.
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Appendix B.3: Media preparation for microbial isolation (MSM-3)
Solutions needed for media:
- Magnesium sulfate solution
In a 100 mL volumetric flask add 12 g K2HPO4. Fill to 100 mL with DDI water.
- Trace metals solution
In a 100 mL volumetric flask add 1 mL of 25% HCl, 150 mg FeCl2.4H2O, 19 mg
CoCl2.6H2O, 10 mg MnCl2.4H2O. 7 mg ZnCl2, 0.6 mg H3BO3, 3.6 mg
Na2MoO4.2H2O, 2.4 mg NiCl2.6H2O, 0.2 mg CuCl2.2H2O, 0.4 g EDTA and 0.3
mg Na2SeO3. Fill to 100 mL with DDI water.
- Vitamin solution
In a 100 mL volumetric flask add 4 mg biotin, 4 mg folic acid, 20 mg pyridoxine
hydrochloride, 10 mg thiamine hydrochloride, 10 mg riboflavin, 10 mg nicotinic
acid, 10 mg DL-calcium pantothenate, 5.2 mg vitamin B12, 10 mg paminobenzoic acid and 10 mg lipoic acid. Fill to 100 mL with DDI water.
Media Preparation:
In a 1 L bottle add 0.5 g NH4Cl, 1.48 g KH2PO4, 3 g NaHCO3, 1.15 mL of 1 g/L
resazurin stock solution. Autoclave this solution, and then add 50 mg of yeast extract,
filter sterilized 1mL MgSO4 solution, 1 mL trace metals solution, 1 mL vitamin solution
and 0.07 g Na2S.9H20.
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Appendix C: IC response factors and standard curves
Table C.1: IC response factors for Fluoride (Retention time of 4.4 minutes)
RF (µg/L/Peak area
Date

units)

R2

7-Sep-2012

418.22

0.9921

16-Sep-2012

431.45

0.9913

3-Oct-2012

427.12

0.9933

8-Oct-2012

397.50

0.9951

15-Oct-2012

419.74

0.9911

2-Nov-2012

428.12

0.9920

12-Nov-2012

448.94

0.9961

21-Nov-2012

426.07

0.9988

30-Nov-2012

451.63

0.9985

19-Dec-2012

458.67

0.9906

18-Apr-2013

429.20

0.9967
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Figure C.1: Summary of fluoride response factors taken at different time intervals.
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Figure C.2: IC response curves for fluoride obtained on 4/18/2013.
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Appendix D: Fluoride standard addition analysis
Table D.1: Standard addition analysis for CFC-11 experimental bottles
Sample
A

B

C

Area
(µS/min)
0.5106
0.4943
0.5226

Fluoride in the
sample (µg/L)a
219
212
224

DHM+CS+B12 #1 (2.5 mL) + 1,000 µg/L
std (2.5 mL)
DHM+CS+B12 #2 (2.5 mL) + 1,000 µg/L
std (2.5 mL)
DHM+CS+B12 #3 (2.5 mL) + 1,000 µg/L
std (2.5 mL)

0.5038

216

0.4613

198

0.5118

220

1,000 µg/L std (2.5 mL)+ DDI #1
(2.5 mL)
1,000 µg/L std (2.5 mL)+ DDI #2
(2.5 mL)
1,000 µg/L std (2.5 mL)+ DDI #3
(2.5 mL)

0.2336

100

0.2379

102

0.2411

103

IC Vial
DHM+CS+B12 #1 (2.5 mL)b
DHM+CS+B12 #2 (2.5 mL)
DHM+CS+B12 #3 (2.5 mL)

Average
Std.
Recoveryc

102
Sample #1
Sample #2
Sample #3

104.6%
90.2%
105.5%

Average
a

b

c

100.1%

All the contents added to the IC vial were diluted 1:50 and passed through a 0.2 um
PTFE filter.
DHM+CS+B12 represents each of the triplicate bottles containing MSM, CS, B12 and
26 mg/L of CFC-11.
Standard recovery of fluoride= ((B-0.5*A)/C )*100; where A=µg/L of fluoride in
experimental sample; B=µg/L of fluoride with 50% of experimental sample + 50% of
1000 µg/L standard, C=µg/L of fluoride with 50% of DDI + 50% of 1000 µg/L
standard.
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Appendix E.1: Set I CFC-11 treatments

Figure E.1: Average of Set I-C treatments containing DHM-1, CS, B12 and CF. Error
bars show standard deviations of duplicate bottles. Arrows represent the addition of corn
syrup.
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Appendix E.2: Set II CFC-11 treatments

Figure E.2: Average of Set II-B treatments containing DHM-1, CS and CFC-11. Error
bars show standard deviations of triplicate bottles. Arrows represent the addition of corn
syrup to the live treatment. Fluoride was monitored over time.

Figure E.3: Average of Set II-C treatments containing MSM, B12 and CFC-11. Error bars
show standard deviations of triplicate bottles. Fluoride was monitored over time.

67

Figure E.4: Average of Set II-D treatments containing only MSM and CFC-11. Error
bars show standard deviations of triplicate bottles. Fluoride was monitored over time.
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Appendix E.3: Set III CFC-11 treatments

Figure E.5: Average of Set III-A treatments containing DHM-1, CS, B12 and CFC-11.
Error bars show standard deviations of triplicate bottles. Arrows represent the addition of
corn syrup to the live treatment. Fluoride monitored at the start and end of the
incubation.

Figure E.6: Average of Set III-B treatments containing DHM-1, CS and CFC-11. Error
bars show standard deviations of triplicate bottles. Arrows represent the addition of corn
syrup to the live treatment. Fluoride was monitored at the start and end of the incubation.
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Figure E.7: Average of Set III-C treatments containing MSM, B12 and CFC-11. Error
bars show standard deviations of triplicate bottles. Fluoride was monitored at the start and
end of the incubation period.

Figure E.8: Average of Set III-D treatments containing only DHM-1and CFC-11. Error
bars show standard deviations of triplicate bottles. Fluoride was monitored at the start and
end of the incubation period.
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Appendix E.4: CF degradation rates by regression analysis
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Figure E.9: Regression analysis for 1E-08 % inoculum dose treatment using four time
points. The treatment used triplicate bottles. Slope represents the degradation rate of CF
in mgL-1day-1.

71

Appendix F: Effect of CF and H2 on DCM degradation

Figure F.1: Average DCM and CF levels in treatments provided with 173 mg/L DCM
and 1 mg/L CF. Error bars represent the standard deviation of duplicates.

Figure F.2: Average DCM levels in treatments provided with 173 mg/L DCM. No CF
was added to them. Error bars represent the standard deviation of duplicate bottles.
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Figure F.3: Average DCM levels in treatments provided with173 mg/L DCM and 4-60
µmol/bottle of hydrogen gas. Error bars represent the standard deviation of duplicate
bottles.

Figure F.4: Average hydrogen and methane levels in treatments provided with 4-60
µmol/bottle of hydrogen gas. Error bars represent the standard deviation of duplicate
bottles.
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Appendix G: Effect of CF on DCM degradation

a

b

Figure G.1: CF inhibition of DCM degradation; a) DCM consumption in treatments
containing CF > 1mg/L and b) CF levels in treatments set up to assess CF inhibition of
DCM.
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